Stockreport

Agile Could Reach $10/Share After Twirla Approval [Seeking Alpha]

Agile Therapeutics, Inc.  (AGRX) 
Last agile therapeutics, inc. earnings: 5/2 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.agiletherapeutics.com/investor-relations
PDF Agile Therapeutics (NASDAQ: AGRX has received approval FDA here So, what's next for the company and its stock price? The future is bright. Twirla's Commercial Prospects [Read more]